Clinicopathologic analysis of 38 male breast cancers
10.19538/j.cjps.issn1005-2208.2019.08.22
- Author:
Hai-li LI
1
;
Jue ZHOU
1
;
Xiu-peng JIA
1
Author Information
1. Clinical Pathology Diagnostic Center of Ningbo Ningbo 315000, China
- Publication Type:Journal Article
- Keywords:
male breast cancer;
clinicopathologic feature;
the second primary cancer
- From:
Chinese Journal of Practical Surgery
2019;39(08):850-853
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: To analyze the clinicopathologic characteristics and molecular subtype in male breast cancer(MBC). METHODS: The clinical features, histological features and molecular subtype of 38 cases of male breast cancers admitted from January 2013 to March 2019 in Clinical Pathology Diagnostic Center of Ningbo were analyzed retrospectively. RESULTS: Thirty-eight patients were diagnosed with MBC, accounting for 0.83% of all the breast cancer in the same term. The median age was 68.5(range from 24 to 88). Tumor were located in left side in 20 cases, right side in 18 cases. Twenty-nine cases were diagnosed as invasive ductal carcinoma, two cases of secretory breast cancer, one case of invasive solid papillary carcinoma, two cases of intraductal papillary carcinoma with microinvasive, and four cases of encapsulated papillary carcinoma(two of them with microinvasive). Sixteen patients had lymphatic metastasis when the tumor was diagnosed. Imunohistochemically, ER was positive in 36 cases, while PR was positive in 35 cases.Eighteen cases were Luminal A type, while sixteen were Luminal B type and two cases were basal-like subtype.CONCLUSION: MBC is a rare malignant neoplasm, and most patients are diagnosed older and at advanced clinical stage,what is more, there is more possibility of second non-breast primary cancer. All suggesting that early diagnosis,treatment and more intensive surveillance are important. MBC needs further study.
